GPT and Hepatic steatosis: A subgroup analysis of the 25 patients (S2 Table), who were diagnosed as hepatic steatosis by ultrasonography before the study, confirmed that treatment of ipragliflozin also significantly improved liver dysfunction assessed by serum ALT levels (S7A Fig).